NRXP 8-K 2026-10-05

NRX Pharmaceuticals, Inc. (NRXP) 8-K dated 2026-10-05 — accession 0001437749-26-032042.

NRX Pharmaceuticals, Inc. (NRXP) is a biotechnology company listed on US.

NRX Pharmaceuticals, Inc. filed a 8-K on 2026-10-05. Accession 0001437749-26-032042.

This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NRXP revenue for 2025-12-31 was $1.2M. Net income was -$28.6M. NRXP currently screens at market cap $169.9M.

Not investment advice. The NRXP SEC hub lists recent forms. The stock page is the research view.